Skip to main content
OpenTrials
Completed

NCT Number: NCT07603869

Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens.

In line with this call for public health diagnosis of CV health, the ESC, through the European Association of Preventive Cardiology (EAPC), is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Preventive Cardiology Congress 2026 from 23-24 April 2026 in Ljubljana, Slovenia.

The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Risks

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cankarjev Dom

Ljubljana, 1000, Slovenia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All attendees including healthcare professionals (doctors, nurses, etc.) attending the EAPC Congress 2026 from 23 to 24 April 2026
  • Subjects who declare that they are able to understand and give IC in English

Exclusion criteria

  • Subjects not willing to provide his/her consent to participate in the study.
  • Subjects who are not suitable candidates for blood extraction.

Treatment and study plan

Questionnaire and Physical Exam

Behavioral

Questionnaire EQ-5D-5L with some lifestyle habits and medical history

Blood Draw

Biological

Blood draw

Primary outcomes

  1. Second Manifestations or Arterial Disease (SMART) algorithm in patients with established CVD

    Time frame: At time of visit

  2. Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm in patients without established CVD

    Time frame: At time of visit

Sponsors and collaborators

Lead sponsor

European Society of Cardiology

Network

Registry information

Official study title

Cross-Sectional Assessment of Cardiovascular Risk Among EAPC Congress 2026 Participants

Acronym: EAPC-CVRISK 20

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 22, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.